Source: International Congress 2019 – Granulomatous disorders: from bench to bedside
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Ohira (Sapporo, Japan), K. Yoshinaga (Chiba, Japan), S. Sakiyama (Sapporo, Japan), T. Nakaya (Sapporo, Japan), N. Suzuki (Sapporo, Japan), A. Sugimoto (Sapporo, Japan), A. Hayashishita (Sapporo, Japan), O. Manabe (Sapporo, Japan), N. Oyama-Manabe (Sapporo, Japan), T. Watanabe (Sapporo, Japan), I. Tsujino (Sapporo, Japan). Prediction of corticosteroid responder in newly diagnosed cardiac sarcoidosis patients with complete heart block. 5159

Member's Comments

No comment yet.

Related content which might interest you: Follow-up of the patients with newly diagnosed sarcoidosis treated with oral corticosteroids. Features associated with chronic sarcoidosis Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases Year: 2008 A respiratory perspective on long term beta-blocker treatment in patients presenting with acute cardiac disease Source: Annual Congress 2010 - Bronchodilator treatment for asthma and COPD Year: 2010 Long-term response to prednisone in newly treated patients with pulmonary sarcoidosis Source: Virtual Congress 2021 – Better understanding of sarcoidosis: new keys Year: 2021 The frequency and types of cardiac arrhythmias in patients who suffer from COPD and chronic pulmonary heart treated in the special hospital ²Sokobanja² – Sokobanja Source: Eur Respir J 2006; 28: Suppl. 50, 162s Year: 2006 Incorporating patients with chronic heart failure (CHF) into pulmonary rehabilitation (PR): a propensity matched analysis Source: Virtual Congress 2020 – Optimising the benefits of pulmonary rehabilitation Year: 2020 Evaluation of a new cardiac arrhythmias predictor in patients with COPD Source: International Congress 2018 – Cardiovascular morbidities in COPD Year: 2018 Timing of cardiac sarcoidosis in patients with sarcoidosis> Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases Year: 2017 Evaluating the prognosis of cardiac and pulmonary patients Source: Course 2015 - Clinical exercise testing Year: 2015 Evaluating the prognosis of cardiac and pulmonary patients Source: School Course 2013 - Clinical exercise testing Year: 2013 Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study Source: Eur Respir J 2012; 40: 101-109 Year: 2012 Clinical and functional characteristics of patients with acute severe COPD with or without ischemic heart disease Source: Eur Respir J 2006; 28: Suppl. 50, 162s Year: 2006 Abnormal heart rate variability in patients with sarcoidosis Source: Annual Congress 2012 - Cystic lung diseases: lung granulomatosis Year: 2012 Assessment of cardiac involvement in patients with sarcoidosis Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases Year: 2011 Role of aerosolized therapy in the incidence of cardiac rythm disturbances in patients hospitalized with a COPD exacerbation Source: Virtual Congress 2020 – Prognosis and integrated management of COPD Year: 2020 The relation of ventricular ectopic beats with pulmonary hypertension in patients with systemic sarcoidosis without clinical evidence of cardiac involvement Source: Eur Respir J 2004; 24: Suppl. 48, 280s Year: 2004 Prevalence of heart disease in patients hospitalized for an acute exacerbation of COPD: Impact on clinical outcome. A 6 month follow-up study Source: Annual Congress 2011 - COPD management Year: 2011 The difficulties of functional class heart failure assessment in the patients with concomitant chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 Survival predictors in a cohort of patients with idiopathic pulmonary fibrosis biopsy-proven Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV Year: 2012